Author detail
Articles by A. Jacobs
- Endocrine disruption and the USFDA's Center for Drug Evaluation and Research
- Risk management options for endocrine disruptors in national and international programs
Coauthors
- J. C. Lamb, IV (1 article)
- J. E. Fisher (1 article)
- G. Lyons (1 article)
- James Farrelly (1 article)
- G. Timm (1 article)
- R. Becker (1 article)
- T. Inoue (1 article)
- M. Matsumoto (1 article)
- Paul Brown (1 article)
- A. Gies (1 article)
- D. Morse (1 article)
- Les Davies (1 article)
- H. B. W. M. Koëter (1 article)
Affiliations
- BBL Sciences, BBL, Inc., Reston, VA 20190, USA; Organization for Economic Cooperation and Development, Paris, France; American Chemical Council, USA; UBA, Germany; Department of Health and Ageing, Australia; NIHS, Japan; U.S. Food and Drug Administration, USA; World Wildlife Fund, UK; Chemical Management Policy Division, Ministry of Economy, Trade and Industry, 1-3-1Kasumigaseki, Chiyoda-ku, Tokyo 100-8901, Japan; U.S. Environmental Protection Agency, USA
- U.S.Food and Drug Administration, HFD-540 5600 Fishers Lane, Rockville, MD 20857,USA